REMEDY : BNSSG referral pathways & Joint Formulary


Home > Adults > Neurology >

Neurophysiology

Checked: 23-08-2022 by katy baetjer Next Review: 23-08-2024

Clinical Guidelines

There are local guidelines on the use of Clinical Neurophysiology which give advice on appropriate (and inappropriate) referrals to their service. Referrals are triaged by the neurophysiology team an may be returned if an investigation is not felt to be indicated.

The Neurophysiology service offers the following tests:

Nerve conduction studies (NCS) and electromyography (EMG).

Electroencephalopathy (EEG).

If clinicians are unsure about the appropriateness of a referral they are encouraged to contact one of the consultants to discuss a case:

Dr Nick Kane Tel: 0117 4141050 (Tuesday and Thursday) or email: Nick.Kane@nbt.nhs.uk.

Dr Agyepong Oware Tel: 0117 4141050 (Monday & Friday) or email: agyepong.oware@nbt.nhs.uk

Dr Sabine Klepsch Tel: 0117 4141050 (Wednesday and Thursday) or email Sabine.Klepsch@nbt.nhs.uk

Referral

NBT

Nerve conduction studies at NBT can now be accessed through e-Referral (under Diagnostic Physiological Measurement - Neurophysiology-Nerve Conduction Studies).

UHBW

Nerve conduction studies at UHBW are now accessible via ICE (search on 'neurophysiology' to bring up referral form)

GPs with access to ICE should refer via this route. For those GPs without access to the ICE system, email: clinicalneurophysiology@uhbw.nhs.uk. The Neurophysiology department at the BRI/BRHC currently only accept direct GP referrals for Nerve Conduction Studies (NCS) and Electromyography (EMG).



Efforts are made to ensure the accuracy and agreement of these guidelines, including any content uploaded, referred to or linked to from the system. However, BNSSG ICB cannot guarantee this. This guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer, in accordance with the mental capacity act, and informed by the summary of product characteristics of any drugs they are considering. Practitioners are required to perform their duties in accordance with the law and their regulators and nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.

Information provided through Remedy is continually updated so please be aware any printed copies may quickly become out of date.